COLL vs LYV · P/E 17, rev $181.9M vs P/E 49, rev $23.16B
Collegium Pharmaceutical Inc (COLL) versus Live Nation Entertainment Inc (LYV) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Live Nation Entertainment Inc (LYV) is a entertainment company listed on US.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported LYV revenue for 2024-12-31 was $23.16B. Net income was $1.13B. Revenue was up 1.9% from 2023-12-31 to 2024-12-31. LYV currently screens at market cap $33.36B and trailing P/E 48.8.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. LYV currently screens at market cap $33.36B and trailing P/E 48.8.
Not investment advice. Open the COLL and LYV stock pages for the full models.
Not investment advice.